长效β-受体激动剂与吸入型糖皮质激素联合治疗哮喘

被引:17
作者
王彤
机构
[1] 南京医科大学第一附属医院
关键词
吸入型糖皮质激素; 吸入激素; 支气管哮喘; 哮喘; 受体; 激动剂; 联合治疗;
D O I
暂无
中图分类号
R562.25 [];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:60 / 61
页数:2
相关论文
共 10 条
[1]  
Allergy[P]. 英国专利:GB202319091D0,2024-01-31
[2]  
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid.Allen &Hanburys Limited UK Study Group. Greening AP,Ind PW,Northfield M,et al. The Lancet . 1994
[3]  
SeretideTM(salmeterol 50 mcg fluticasone propionate 250 mcg bid) compared with budesonide(800mcg)bid. Jenkins C,Woolcock AJ,Saarelainen P,et al. Respiratory Medicine . 2000
[4]  
Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. Baraniuk JN,Ali M,Brody D,et al. American Journal of Respiratory and Critical Care Medicine . 1997
[5]  
Anti-inflammatory actions of steroids: molecular mechanisms. Barnes PJ,Adcock IM. Trends in Pharmacological Sciences . 1993
[6]  
Sustained activation of a G protein couple receptor via"anchored"agonist binding: molecular localization of the salmeterol exosite within the beta 2-adrenergic receptor. Green SA,Spasoff AP,Coleman RA,et al. Journal of Biological Chemistry . 1996
[7]  
Inhaled fluticasone propionate and salmeterol in moderate adult asthma: lung and symptoms. Ind PW,Dal Negro R,Colman NC,et al. American Journal of Respiratory and Critical Care Medicine . 1998
[8]  
Bronchial biopsy study in asthmatics treated with low and high dose FP compared to low dose FP combined with salmeterol. Sue CM,Wallin A,Wilson S,et al. European Respiratory Journal . 1999
[9]  
The β- adrenoceptor. Johnson M. American Journal of Respiratory and Critical Care Medicine . 1998
[10]  
A meta-analysis of increasing inhaled steroid or adding salmeterol in symptomatic asthma. Shrewsbury SB,Pyke SD,Britton M. British Medical Journal . 2000